| |
亀岡 正典 （原著論文） |
|
 |
|
|
| |
2025:
Shiroma, H., Chikamoto, A., Kameoka, M., Kumagai, K., Matsuyama, H. and Ichihashi, Y. Antimicrobial and antiviral activities and reaction mechanisms of an organic photocatalyst upon visible-light irradiation. Res. Chem. Intermed. in press
2024:
Churrotin, S., Amarullah, I. H., Fitria, A. L., Khairunisa, S. Q., Yamani,
L N., Kameoka, M., Anggraeni, N., Nurhariansyah, R., Husada, D. and Wungu,
C. D. K. Cross-reactivity between Dengue virus and SARS-CoV-2 Antibodies:
Confirmation Study using Specimens from Dengue-Infected Patients before
the COVID-19 Pandemic. Heliyon 10(21):e39099, 2024.
Aoki-Utsubo, C., Kameoka, M., Deng, L., Hanafi, M., Dewi, B. E., Sudarmono, P., Wakita, T. and Hotta, H. Statins enhance extracellular release of hepatitis C virus particles through ERK5 activation. Microbiol. Immunol. 68(10):359-370, 2024.
Rachman, B. E., Khairunisa, S. Q., Wungu, C. D. K., Asmarawati, T. P., Rusli, M., Bramantono, Arfijanto, M. V., Hadi, U., Kameoka, M. and Nasronudin. Low clinical impact of HIV drug resistance mutations in oral pre-exposure prophylaxis: A systematic review and meta-analysis. AIDS Res. Ther. 21(1):37, 2024.
Rachman, B. E., Megasari, N. L. A., Khairunisa, S. Q., Kotaki, T., Arfijanto, M. V., Hadi, U., Nasronudin and Kameoka, M. Genotypic analysis of transmitted and acquired HIV drug resistance in people living with HIV/AIDS in Surabaya, Indonesia, from 2018 to 2019. Acta Med. Indones. 56(2):168-175, 2024.
Khairunisa, S. Q., Indriati, D. W., Megasari, N. L. A., Ueda, S., Kotaki,
T., Fahmi, M., Ito, M., Rachman, B. E., Hidayati, A. N., Nasronudin and
Kameoka, M. Spatial–temporal transmission dynamics of HIV-1 CRF01_AE in
Indonesia. Sci. Rep. 14:9917, 2024.
Tada, T., Zhang, Y., Kong, D., Tanaka, M., Yao,W., Kameoka, M., Ueno, T., Fujita, H. and Tokunaga, K. Further characterization of the antiviral transmembrane protein MARCH8. Cells. 13(8):698, 2024.
2023:
Aoki-Utsubo, C., Hanafi, M., Armanti, D. T., Fuchino, H., Kawahara, N., Hartati, S., Widyawaruyanti, A., Sudarmono, P., Kameoka, M. and Hotta, H. Identification of an Oligostilbene, Vaticanol B, from Dryobalanops aromatica Leaves as an Antiviral Compound against the Hepatitis C Virus. Biol. Pharm. Bull. 46:1079-1087, 2023.
Takazawa, S., Kotaki, T., Nakamura, S., Utsubo, C. and Kameoka, M. Construction
of Fosmid-based SARS-CoV-2 replicons for antiviral drug screening and replication
analyses in biosafety level 2 facilities. Virus Res. 334:199176, 2023.
Masyeni, S, Budhitresna, A. A. G., Adiwinata, R., Wibawa, S., Nugraha, P. A., Antara, J., Asmara, D. P. G. W., Widyaningsih, P. D., Yenny, L. G. S., Widiastika, M., Kahari, S., Wardhana, C. A., Pasek, A. W., Putrawan, O., Santosa, A., Herawati, S., Arisanti, N. L. P. E., Astini, W., Fatawy, R. M., Kameoka, M. and Nelwan, E. J. The role of CD4+, CD8+, CD4+/CD8+ and neutrophile to lymphocyte ratio in predicting and determining COVID-19 severity in Indonesian patients. Trans. R. Soc. Trop. Med. Hyg. 6:trad012, 2023.
Aoki-Utsubo, C., Indrasetiawan, P., Fukano, K., Muramatsu, M., Artanti, N., Hanafi, M., Hotta, H. and Kameoka, M. Amentoflavone inhibits hepatitis B virus infection via the suppression of preS1 binding to host cells. Microbiol. Immunol. 67:281-292, 2023.
Bule, Y. P., Nagai, Y. and Kameoka, M. Viability and acceptability of self-sampling as a primary screening method for sexually transmitted infections in female Kobe University students. Bulletin of health sciences Kobe 38:29-43, 2023.
Khairunisa, S. Q., Megasari, N. L. A., Ueda, S., Kotaki, T., Hidayati, A. N., Nasronudin and Kameoka, M. Subtype distribution and drug resistance patterns among HIV-1 strains prevalent in Makassar, Indonesia. AIDS Res. Hum. Rertoviruses 39(3):124-129, 2023.
2022:
Nakamura, A., Kotaki, T., Nagai, Y., Takazawa, S., Tokunaga, K. and Kameoka,
M. Construction and evaluation of a self-replicative RNA vaccine against
SARS-CoV-2 using yellow fever virus replicon. PLoS ONE 17(10):e0274829,
2022.
Kotaki, T., Nagai, Y., Yamanaka, A., Konishi, E. and Kameoka, M. Japanese encephalitis DNA vaccines with epitope modification reduced the induction of cross-reactive antibodies against dengue virus and antibody-dependent enhancement of dengue virus infection. Vaccines 10(9):1411, 2022.
Takaichi, M., Osawa, K., Nomoto, R., Nakanishi, N., Kameoka, M., Miura, M., Shigemura, K., Kinoshita, S., Kitagawa, K., Uda, A., Miyara, T., Mertaniasih, N. M., Hadi, U., Raharjo, D., Yulistiani, R., Fujisawa, M., Kuntaman and Shirakawa, T. Antibiotic Resistance in Non-Typhoidal Salmonella enterica Strains Isolated from Chicken Meat in Indonesia. Pathogens 11(5):543, 2022.
Urushidani, M, Kawayoshi, A., Kotaki, T., Saeki, K., Mori, Y. and Kameoka,
M. Inactivation of SARS-CoV-2 and influenza A virus by dry fogging hypochlorous
acid solution and hydrogen peroxide solution. PLoS ONE 17(4):e0261802.
2022.
Zhang, Y., Ozono, S., Tada, T., Tobiume, M., Kameoka, M., Kishigami, S.,
Fujita, H. and Tokunaga, K. MARCH8 Targets Cytoplasmic Lysine Residues
of Various Viral Envelope Glycoproteins. Microbiol. Spectr. 10(1):e00618-21,
2022.
2021:
Kotaki, T., Kurosu, T., Grinyo-Escuer, A., Davidson, E., Churrotin, S.,
Okabayashi, T., Puiprom, O., Mulyatno, K. C., Sucipto, T. H., Doranz, B.
J., Ono, K., Soegijanto, S. and Kameoka, M. An affinity-matured human monoclonal
antibody targeting fusion loop epitope of dengue virus with in vivo therapeutic
potency. Sci. Rep. 11:12987, 2021.
Kotaki, T., Xie, X., Shi, P.-Y. and Kameoka, M. A PCR amplicon–based SARS-CoV-2
replicon for antiviral evaluation. Sci. Rep. 11(1):2229, 2021.
Kotaki, T., Yamanaka, A., Konishi, E. and Kameoka, M. A potent neutralizing mouse monoclonal antibody specific to dengue virus type 1 Mochizuki strain recognized a novel epitope around the N-67 glycan on the envelope protein: a possible explanation of dengue virus evolution regarding the acquisition of N-67 glycan. Virus Res. 294:198278, 2021.
2020:
Indriati, D. W., Witaningrum, A. M., Yunifiar, M. Q., Khairunisa, S. Q., Ueda, S., Kotaki, T., Nasronudin and Kameoka, M. The Dominance of CRF01_AE and the Emergence of Drug Resistance Mutations Among Antiretroviral Therapy-Experienced, HIV-1-infected Individuals in Medan, Indonesia. Acta Med. Indones. 52(4):366-374, 2020.
Ophinni, Y., Miki, S., Hayashi, Y. and Kameoka, M. Multiplexed tat-targeting CRISPR-Cas9 protects T cells from acute HIV-1 infection with inhibition of viral escape. Viruses 12(11):E1223, 2020.
Khairunisa, S. Q., Megasari, N. L. A., Ueda, S., Budiman, W., Kotaki, T., Nasronudin and Kameoka, M. 2018-2019 Update on the Molecular Epidemiology of HIV-1 in Indonesia. AIDS Res. Hum. Rertoviruses 36(11):957-963, 2020.
Khairunisa, S. Q., Megasari, N. L. A., Indriati, D. W., Kotaki, T., Natalia, D., Nasronudin and Kameoka, M. Identification of HIV-1 subtypes and drug resistance mutations among HIV-1-infected individuals residing in Pontianak, Indonesia. GERMS 10(3):174-183, 2020.
Nukuzuma, S., Nukuzuma, C., Kameoka, M., Sugiura, S., Nakamichi, K., Tasaki,
T., Hidaka, K. and Takegami, T. Characterziation of JC polyomavirus derived
from COS-IMRb cells. Jpn. J. Infect. Dis. 74(1):48-53, 2020.
Khairunisa, S. Q., Megasari, N. L. A., Rahayu, R. P., Witaningrum, A. M.,
Ueda, S., Yunifiar, M. M. Q., Indriati, D. W., Kotaki, T., Rusli, A., Nasronudin
and Kameoka, M. Detection of human immunodeficiency virus type 1 transmitted
drug resistance among treatment-naive individuals residing in Jakarta,
Indonesia. Infect. Dis. Rep. 12(s1):8740, 2020.
Sasaki, M., Kotaki, T., Khairunisa, S. Q., Tachibana, S., Ophinni, Y.,
Hayashi, Y., Nasronudin and Kameoka, M. Characterization of HIV-1 CRF01_AE
env genes derived from recently infected Indonesian individuals. AIDS Res.
Hum. Rertoviruses 36(3):242-247, 2020.
2019:
Ueda, S., Witaningrum, A. M., Khairunisa, S. Q., Kotaki, T., Motomura, K., Nasronudin and Kameoka, M. Transmission dynamics of HIV-1 subtype B strains in Indonesia. Sci. Rep. 9(1):13986, 2019.
Chaitaveep, N., Utachee, P., Tabprasit, S., Chuenchitra, T. and Kameoka, M. Comparison of antibody-dependent cellular cytotoxicity activity elicited in recent and chronic HIV-1-infected Thai individuals. Southeast Asian J. Trop. Med. Public Health 50(4):651-662, 2019.
Indrasetiawan, P., Aoki-Utsubo, C., Hanafi, M., Hartati, S., Wahyuni, T.
S., Kameoka, M., Yano, Y., Hotta, H. and Hayashi, Y. Antiviral activity
of Cananga odorata against Hepatitis B virus. Kobe J. Med. Sci. 65(2):E71-E79,
2019.
Oka, T., Negi, B. S., Ueda, S., Sasaki, M., Kotaki, T. and Kameoka, M. Genotypic characterization of HIV-1 subtype C in the central region of Nepal. AIDS Res. Hum. Rertoviruses 35(9):870-875, 2019.
Megasari, N. L. A., Oktafiani, D., Fitriana, E., Khairunisa, S. Q., Ueda,
S., Kotaki, T., Nasronudin, Soetjipto and Kameoka, M. The emergence of
HIV-1 transmitted drug resistance mutations among antiretroviral therapy-naive
individuals in Buleleng, Bali, Indonesia. Acta Med. Indones. 51(3):197-204,
2019.
Megasari, N. L. A., Oktafiani, D., Ana, E. F., Ueda, S., Kotaki, T., Nasronudin, Soetjipto and Kameoka, M. Genotypic characterization of human immunodeficiency virus type 1 isolated from ART-experienced individuals in Buleleng Regency, Bali, Indonesia. AIDS Res. Hum. Rertoviruses 35(8):769-774, 2019.
Nakashima, T., Suga, T., Kameoka, M., Ueno, M., Inahashi, Y., Matsuo, H., Iwatsuki, M., Shigemura, K., Shiomi, K., Takahashi, Y., Omura, S. and Kimura, T. New tetrahydroquinoline and indoline compounds containing a hydroxy cyclopentenone, virantmycin B and C, produced by Streptomyces sp. AM-2504. J. Antibiot. 72(3):169-173, 2019.
Ueda, S., Witaningrum, A. M., Khairunisa, S. Q., Kotaki, T., Nasronudin
and Kameoka, M. Genetic Diversity and Drug Resistance of HIV-1 Circulating
in North Sulawesi, Indonesia. AIDS Res. Hum. Retroviruses 35(4): 407-413,
2019.
2018:
Witaningrum, A. M., Khairunisa, S. Q., Ueda, S., Yunifiar, M. Q., Indriati,
D. W., Kotaki, T., Rusli, A., Nasronudin and Kameoka, M. Viral subtyping
of HIV-1 derived from infected, drug-naive individuals in Jakarta, Indonesia.
OP Conf. Ser.: Mater. Sci. Eng. 434 012321, 2018.
Nukuzuma, S., Nukuzuma, C., Kameoka, M., Sugiura, S., Nakamichi, K., Tasaki,
T., Hidaka, K. and Takegami, T. Establishment of COS-JC cells persistently
producing archetype JC polyomavirus. Microbiol. Immunol. 62(8): 524-530,
2018.
Negi, B. S., Joshi, S. K., Nakazawa, M., Kotaki, T., Bastola, A. and Kameoka, M. Impact of a massive earthquake on adherence to antiretroviral therapy, mental health, and treatment failure among people living with HIV in Nepal. PLoS ONE 13(6): e0198071, 2018.
Hidaka, K., Kimura, T., Sankaranarayanan, R., Wang, J., McDaniel, K., Kempf,
D., Kameoka, M., Adachi, M., Kuroki, R., Nguyen, J.-T., Hayashi, Y. and
Kiso, Y. Identification of highly potent human immunodeficiency virus type-1
protease inhibitors against lopinavir and darunavir resistant viruses from
allophenylnorstatine-based peptidomimetics with P2 tetrahydrofuranylglycine.
J. Med. Chem. 61(12): 5138-5153, 2018.
Ophinni, Y., Inoue, M., Kotaki, T. and Kameoka, M. CRISPR/Cas9 system targeting
regulatory genes of HIV-1 inhibits viral replication in infected T-cell
cultures. Sci. Rep. 8: 7784, 2018.
Indriati, D. W., Kotaki, T., Khairunis, S. Q., Witaningrum, A. M., Yunifiar M., M. Q., Ueda, S., Nasronudin, Purnama, A., Kurniawan, D. and Kameoka, M. Appearance of drug resistance mutations among the dominant HIV-1 subtype, CRF01_AE in Maumere, Indonesia. Curr. HIV Res. 16(2): 158-166, 2018.
Sucipto, T. H., Churrotin, S., Setyawati, H., Martak, F., Mulyatno, K. C., Amarullah, I. H., Kotaki, T., Kameoka, M., Yotopranoto, S. and Soegijanto, A. S. A new copper (II)-imidazole derivative effectively inhibits replication of DENV-2 in vero cells. Afr. J. Infect. Dis. 12(1 Suppl): 116-119, 2018.
Khairunisa, S. Q., Ueda, S., Witaningrum, A. M., Yunifiar M., M. Q., Indriati, D. W., Kotaki, T., Nasronudin and Kameoka, M. Genotypic characterization of HIV-1 prevalent in Kepulauan Riau, Indonesia. AIDS Res. Hum. Retroviruses 34(6): 555-560, 2018.
Sucipto, T. H., Kotaki, T., Mulyatno, K. C., Churrotin, S., Labiqah, A.,
Soegijanto, S. and Kameoka, M. Phylogenetic Analysis of Dengue Virus in
Bangkalan, Madura Island, East Java Province, Indonesia. J. Trop. Med.
2018: 8127093, 2018.
Khairunisa, S. Q., Masyeni, S., Witaningrum, A. M., Yunifiar M., M. Q.,
Indriati, D. W., Kotaki, T., Ueda, S., Budiyasa, D. G., Nasronudin and
Kameoka, M. Genotypic characterization of human immunodeficiency virus
type 1 isolated in Bali, Indonesia in 2016. HIV AIDS Rev. 17(2): 81-90,
2018.
Tian, Y.-S., Takagi, T., Kameoka, M. and Kawashita, N. Dengue virus and its inhibitors: a brief review. (Review) Chem. Pharm. Bull. (Tokyo) 66(3): 191-206, 2018.
Mulyatno, K. C., Kotaki, T., Yotopranoto, S., Rohmah, E. A., Churotin,
S., Sucipto, T. H., Amarullah, I. H., Wardhani, P., Soegijanto, S. and
Kameoka, M. Detection and serotyping of dengue viruses from Aedes aegypti
and Aedes albopictus (Diptera: Culicidae) collected in Surabaya, Indonesia
2008 - 2015. Jpn. J. Infect. Dis. 71(1): 58-61, 2018.
2017:
Chen, M., Aoki-Utsubo, C., Kameoka, M., Deng, L., Terada, Y., Kamitani, W., Sato, K., Koyanagi, Y., Hijikata, M., Shindo, K., Noda, T., Kohara, M. and Hotta, H. Broad-spectrum antiviral agents: secreted phospholipase A2 targets viral envelope lipid bilayers derived from the endoplasmic reticulum membrane. Sci. Rep. 7(1): 15931, 2017.
Yunifiar M., M. Q., Kotaki, T, Witaningrum, A. M., Khairunisa, S. Q., Indriati,
D. W., Meilani, Yeheskiel, T., Ueda, S., Nasronudin and Kameoka, M. Sero-
and molecular epidemiology of HIV-1 in Papua province, Indonesia. Acta
Med. Indones. 49(3): 205-214, 2017.
Tachibana, S., Sasaki, M., Tanaka, T., Inoue, M., Ophinni. Y., Kotaki, T. and Kameoka, M. A 2-4-amino acid deletion in the V5 Region of HIV-1 Env gp120 confers viral resistance to the broadly neutralizing human monoclonal antibody, VRC01. AIDS Res. Hum. Retroviruses 33(12): 1248-1257, 2017.
Nukuzuma, S., Nukuzuma, C., Kameoka, M., Sugiura, S., Nakamichi, K., Tasaki, T. and Takegami, T. CPT11 prevents virus replication in JCI cells persistently infected with JC polyomavirus. Microbiol. Immunol. 61: 232-238, 2017.
Negi, B. S., Kotaki, T., Joshi, S. K., Bastola, A., Nakazawa, M. and Kameoka, M. Genotypic characterization of human immunodeficiency virus type 1 derived from antiretroviral drug-treated individuals residing in earthquake-affected areas in Nepal. AIDS Res. Hum. Retroviruses 33: 960-965, 2017.
Inoue, M., Oyama, D., Hidaka, K. and Kameoka, M. Evaluation of novel protease inhibitors against darunavir-resistant variants of human immunodeficiency virus type 1. FEBS Open Bio 7 (1): 88-95, 2017.
2016:
Tian, Y.-S., Kawashita, N., Kameoka, M. and Takagi, T. Novel Anti-Human
Immunodeficiency Virus Compounds with Activity against Cyclophilin A: A
Look Back. J. Prev. Inf. Cntrl. 2(2): 12, 2016.
Fahmi, M. Z., Sukmayani, W., Khairunisa, S. Q., Witaningrum, A. M., Indriati,
D. W., Matondang, M. Q. Y., Chang, J.-Y., Kotaki, T. and Kameoka, M. Design
of boronic acid-attributed carbon dots on inhibits HIV-1 entry. RSC Adv.
6: 92996-93002, 2016.
Witaningrum, A. M., Kotaki, T., Khairunisa, S. Q., Yunifiar M, M. Q., Indriati,
D. W., Bramanthi, R., Nasronudin and Kameoka, M. Genotypic characterization
of human immunodeficiency virus type 1 derived from antiretroviral therapy-naïve
individuals residing in Sorong, West Papua. AIDS Res. Hum. Retroviruses
32: 812-817, 2016.
Churrotin, S., Kotaki, T., Sucipto, T. H., Ahwanah, N. L. F., Deka, P.
T., Mulyatno, K. C., Utami, D. A. P., Ranasasmita, R., Soegijanto, S. and
Kameoka, M. Dengue virus type 1 strain isolated in Indonesia shows a close
phylogenetic relationship with the strains that caused the autochthonous
dengue outbreak in Japan in 2014. Jpn. J. Infect. Dis. 69 (5): 442-444,
2016.
Nukuzuma, S., Nakamichi, K., Kameoka, M., Sugiura, S., Nukuzuma, C., Tasaki,
T. and Takegami, T. Suppressive effect of topoisomerase inhibitors on JC
polyomavirus propagation in human neuroblastoma cells. Microbiol Immunol.
60: 253-260, 2016.
Chaitaveep, N., Utachee, P., Chuenchitra, T., Karasavvan, N., Takeda, N.
and Kameoka, M. Neutralization breadth and potency of serum derived from
recently human immunodeficiency virus type 1-infected Thai individuals.
Microbes Infect. 18:346-353, 2016.
Yamanaka, A., Oddgun, D., Chantawat, N., Okabayashi, T., Ramasoota, P.,
Churrotin, S., Kotaki, T., Kameoka, M., Soegijanto, S. and Konishi, E.
Dengue virus infection-enhancing antibody activities against Indonesian
strains in inhabitants of central Thailand. Microbes Infect. 18: 277-284,
2016.
2015:
Kotaki, T., Yamanaka, A., Mulyatno, K. C., Churrotin, S., Sucipto, T. H., Labiqah, A., Ahwanah, N. L. F., Soegijanto, S., Kameoka, M. and Konishi, E. Divergence of the dengue virus type 2 Cosmopolitan genotype associated with two predominant serotype shifts between 1 and 2 in Surabaya, Indonesia, 2008-2014. Infect. Genet. Evol. 37: 88-93, 2015.
Verathamjamras, C., Tian, Y.-S., Kawashita, N., Okamoto, K., Yasunaga, T., Ikuta, K., Motomura, K., Takeda, N., Takagi, T. and Kameoka, M. Search for Low Molecular Weight Compounds That Inhibit Human Immunodeficiency Virus Type 1 Replication. J. Infect. Dis. Ther. 3: 218, 2015.
Kotaki, T., Khairunisa, S. Q., Witaningrum, A. M., Yunifiar M., M. Q., Sukartiningrum, S. D., Noordiansyah, M., Rahayu, R. P., Nasronudin and Kameoka, M. HIV-1 Transmitted Drug Resistance Mutations among Antiretroviral Therapy-Naive Individuals in Surabaya, Indonesia. AIDS Res. Ther. 12: 5, 2015.
Nukuzuma, S., Sugiura, S., Nakamichi, K., Kameoka, M., Nukuzuma, C., Tasaki,
T. and Takegami, T. Replication of IMR-32-adapted JC virus clones in human
embryonic kidney cells. Microbiol. Immunol. 59: 238-242, 2015.
Khairunisa, S. Q., Kotaki, T., Witaningrum, A. M., Yunifiar M., M. Q.,
Sukartiningrum, S. D., Nasronudin and Kameoka, M. Appearance of Drug Resistance-Associated
Mutations in Human Immunodeficiency Virus Type 1 Protease and Reverse Transcriptase
Derived from Drug-treated Indonesian Patients. AIDS Res. Hum. Retroviruses
31: 255-259, 2015.
2014:
Sucipto, T. H., Labiqah, A., Churrotin, S., Ahwanah, N., Mulyatno, K. C.,
Soegijanto, S., Kotaki, T., Kameoka, M. and Konishi, E. Molecular Surveillance
of Dengue Virus Serotype Using Polymerase Chain Reaction in Surabaya 2013.
Indonesia. J. Trop. Infect. Dis. 5: 1-4, 2014.
Kotaki, T., Yamanaka, A., Mulyatno, K. C., Churrotin, S., Labiqah, A.,
Sucipto, T. H., Soegijanto, S., Kameoka, M. and Konishi, E. Continuous
Dengue Type 1 Virus Genotype Shifts Followed by Co-circulation, Clade Shifts
and Subsequent Disappearance in Surabaya, Indonesia, 2008-2013. Infect.
Genet. Evol. 28: 48-54, 2014.
Utachee, P., Isarangkura-na-ayuthaya, P., Tokunaga, K., Ikuta, K., Takeda,
N. and Kameoka, M. Impact of amino acid substitutions in the V2 and C2
regions of human immunodeficiency virus type 1 CRF01_AE envelope glycoprotein
gp120 on viral neutralization susceptibility to broadly neutralizing antibodies
specific for the CD4 binding site. Retrovirology 11: 32, 2014.
Kotaki, T., Yamanaka, A., Mulyatno, K. C., Labiqah, A., Sucipto, T. H.,
Churrotin, S., Soegijanto, S., Konishi, E. and Kameoka, M. Phylogenetic
analysis of dengue virus type 3 strains primarily isolated in Surabaya,
Indonesia, in 2013. Jpn. J. Infect. Dis. 67: 227-229, 2014.
Nukuzuma, S., Nakamichi, K., Kameoka, M., Sugiura, S., Nukuzuma, C., Tasaki, T. and Takegami, T. TNF-α stimulates efficient JC virus replication in neuroblastoma cells. J. Med. Virol. 86: 2026-2032, 2014.
Kotaki, T., Khairunisa, S. Q., Sukartiningrum, S. D., Witaningrum, A. M.,
Rusli, M., Diansyah, M. N., Arfijanto, M. V., Rahayu, R. P., Nasronudin
and Kameoka, M. Detection of drug resistance-associated mutations in human
immunodeficiency virus type 1 integrase derived from drug-naïve individuals
in Surabaya, Indonesia. AIDS Res. Hum. Retroviruses 30: 489-492, 2014.
Sjatha, F., Kuwahara, M., Sudiro, T. M., Kameoka, M. and Konishi, E. Evaluation
of chimeric DNA vaccines consisting of premembrane and envelope genes of
Japanese encephalitis and dengue viruses as a strategy for reduced induction
of dengue virus infection-enhancing antibody response. Microbiol. Immunol.
58: 126-134, 2014.
Chaitaveep, N., Utachee, P., Nakamura, S., Chuenchitra, T., Ekpo, P., Takeda,
N., Pattanapanyasat, K. and Kameoka, M. Characterization of human immunodeficiency
virus type 1 CRF01_AE env genes derived from recently infected Thai individuals.
Microbes Infect. 16: 142-152, 2014.
2013:
Soegijanto, S., Sari, D. W., Yamanaka, A., Kotaki, T., Kameoka, M. and
Konishi, E. Awareness of using ringer lactat solution in dengue virus infection
cases could induce severity. Indonesia. J. Trop. Infect. Dis. 4: 35-41,
2013.
Kotaki, T., Khairunisa, S. Q., Sukartiningrum, S. D., Arfijanto, M. V.,
Utsumi, T., Normalina, I., Handajani, R., Widiyanti, P., Rusli, M., Rahayu,
R. P., Lusida, M. I., Hayashi, Y., Nasronudin and Kameoka, M. High prevalence
of HIV-1 CRF01_AE viruses among female commercial sex workers residing
in Surabaya, Indonesia. PLoS ONE 8: e82645, 2013.
Akapirat, S., Avihingsanon, A., Ananworanich, J., Schuetz, A., Ramasoota,
P., Luplertlop, N., Ono, K., Ikuta, K., Utachee, P., Kameoka, M. and Leaungwutiwong,
P. Variables influencing anti-human immunodeficiency virus type 1neutralizing
monoclonalantibody (NHMAb) production among infected Thais. Southeast Asian
J. Trop. Med. Public Health 44: 825-841, 2013.
Sapsutthipas, S., Tsuchiya, N., Pathipavanich, P., Ariyoshi, K., Sawanpanyalert,
P., Takeda, N., Panasda Isarangkura-na-ayuthaya, P. and Kameoka, M. CRF01_AE-specific
neutralizing activity observed in plasma derived from HIV-1-infected Thai
patients residing in northern Thailand: comparison of neutralizing breadth
and potency between plasma derived from rapid and slow progressors. PLoS
ONE 8: e53920, 2013.
Nukuzuma, S., Kameoka, M., Sugiura, S., Nakamichi, K., Nukuzuma, C. and
Takegami, T. Suppressive effect of PARP-1 inhibitor on JC virus replication
in vitro. J. Med. Virol. 85: 132-137, 2013.
Tian, Y.-S., Verathamjamras, C., Kawashita, N., Okamoto K., Yasunaga, T.,
Ikuta, K., Kameoka, M. and Takagi, T. Discovery of novel low-molecular-weight
HIV-1 inhibitors interacting with cyclophilin A using in silico screening
and biological evaluations. J. Mol. Model. 19: 465-475, 2013.
2012:
Li, Y. G., Siripanyaphinyo. U., Tumkosit, U., Noranate, N., A. Nuegoonpipat, A., Pan. Y., Kameoka, M., Takeshi, K., Ikuta, K., Takeda, N. and Anantapreecha, S. Poly (I:C), an agonist of toll-like receptor-3, inhibits replication of the Chikungunya virus in BEAS-2B cells. Virol. J. 9: 114, 2012.
Nukuzuma, S., Kameoka, M., Sugiura, S., Nakamichi, K., Nukuzuma, C., Miyoshi, I. and Takegami, T. Exogenous human immunodeficiency virus-1 protein, Tat, enhances replication of JC virus efficiently in neuroblastoma cell lines. J. Med. Virol. 84: 555-561, 2012.
2011:
Boonchawalit, S., Jullaksorn, D., Uttiyoung, J., Yowang, A., Krathong, N., Chautrakul, S., Yamashita, A., Ikuta, K., Roobsoong, A., Kanitvittaya, S., Sawanpanyalert, P. and Kameoka, M. Molecular evolution of HIV-1 CRF01_AE Env in Thai patients. PLoS ONE 6: e27098, 2011.
Sapsutthipas, S., Kitagawa, Y., Tokunaga, K., Ikuta, K. and Kameoka, M. Viral factors involved in adapter-related protein complex 2 alpha 1 subunit-mediated regulation of human immunodeficiency virus type 1 replication. Southeast Asian J. Trop. Med. Public Health 42: 311-319, 2011.
2010:
Isarangkura-na-ayuthaya, P., Kaewnoo, W., Auwanit, W., de Silva, U. C., Ikuta, K., Sawanpanyalert, P. and Kameoka, M. Appearance of drug resistance-associated mutations in human immunodeficiency virus type 1 CRF01_AE integrase derived from drug-naive Thai patients. AIDS Res. Hum. Retroviruses 26: 1341-1343, 2010.
Nukuzuma, S., Nakamichi, K., Kameoka, M., Sugiura, S., Nukuzuma, C., Miyoshi, I. and Takegami, T. Efficient propagation of progressive multifocal leukoencephalopathy-type JC virus in COS-7-derived cell lines stably expressing Tat protein of human immunodeficiency virus type 1. Microbiol. Immunol. 54: 758?762, 2010.
Soonthornsata, B., Tian, Y.-S., Utachee, P., Sapsutthipas, S., Isarangkura-na-ayuthaya, P., Auwanit, W., Takagi, T., Ikuta, K., Sawanpanyalert, P., Kawashita, N. and Kameoka, M. Design and evaluation of antiretroviral peptides corresponding to the C-terminal heptad repeat region (C-HR) of human immunodeficiency virus type 1 envelope glycoprotein gp41. Virology 405: 157-164, 2010.
Kameoka, M., Isarangkura-na-ayuthaya, P., Kameoka, Y., Sapsutthipas, S, Soonthornsata, B., Nakamura, S., Tokunaga, K., Sawanpanyalert, P., Ikuta, K. and Auwanit, W. The role of lysine residue at amino acid position 165 of human immunodeficiency virus type 1 CRF01_AE Gag in reducing viral drug susceptibility to protease inhibitors. Virology 405: 129-138, 2010.
Li, Y. G., Chittaganpitch, M., Waicharoen, S., Kanai, Y., Bai, G. R., Warachit, J., Kameoka, M., Takeda, N., Ikuta, K. and Sawanpanyalert, P. Characterization of H5N1 influenza viruses in vitro isolated from humans. Virol. J. 7: 112, 2010.
Utachee, P., Nakamura, S., Isarangkura-na-ayuthaya, P., Tokunaga, K., Sawanpanyalert, P., Ikuta, K., Auwanit, W. and Kameoka, M. Two N-linked glycosylation sites in V2 and C2 regions of human immunodeficiency virus type 1 CRF01_AE envelope glycoprotein gp120 regulate viral neutralization susceptibility to the human monoclonal antibody specific for CD4 binding domain. J. Virol. 84: 4311-4320, 2010.
Jullaksorn, D., Boonchawalit, T., Uttiyoung, J., Soonthornsata, B., Yowang, A., Krathong, N., Chautrakul, S., Ikuta, K., Roobsoong, A., Kanitvittaya, S., Sawanpanyalert, P. and Kameoka, M. Sustained appearance of drug resistance-associated mutations in CRF01_AE protease and reverse transcriptase derived from protease inhibitor-naive Thai patients. Southeast Asian J. Trop. Med. Public Health 41: 347-357, 2010.
de Silva, U. C., Warachit, J., Sattagowit, N., Jirapongwattana, C., Panthong, S., Utachee, P., Yasunaga, T., Ikuta, K., Kameoka, M. and Boonsathorn, N. Genotypic characterization of HIV-1 env gp160 sequences from three regions in Thailand. AIDS Res. Hum. Retroviruses 26: 223-227, 2010.
Pongsuwannna, Y., Guntapong, R., Tacharoenmuang, R., Prapanpoj, M., Kameoka, M. and Taniguchi, K. A long-term survey on the distribution of the human G type rotavirus in Thailand. J. Med. Virol. 82: 157-163, 2010.
2009:
Nukuzuma, S., Kameoka, M., Sugiura, S., Nakamichi, K., Nukuzuma, C., Miyoshi, I. and Takegami, T. Archetype JC virus efficiently propagates in kidney-derived cells stably expressing HIV-1 Tat. Microbiol. Immunol. 53: 621-628, 2009.
Jinnopat, P., Isarangkura-na-ayuthaya, P., Utachee, P., Kitagawa, Y., de Silva, U. C., Siripanyaphinyo, U., Kameoka, Y., Tokunaga, K., Sawanpanyalert, P., Ikuta, K., Auwanit, W. and Kameoka, M. Impact of Amino Acid Variations in Gag and Protease of Human Immunodeficiency Virus Type 1 CRF01_AE strains on Drug Susceptibility of Virus to Protease Inhibitors. J. Acquir. Immune Defic. Syndr. 52: 320-328, 2009.
Kameoka, M., Kameoka, Y., Uthachee, P., Kurosu, T., Sawanpanyalert, P., Ikuta, K. and Auwanit, W. RNA Interference Directed Against Axin1 Up-regulates Human Immunodeficiency Virus Type 1 Gene Expression by Activating Wnt Signaling Pathway in HeLa-Derived J111 Cells. AIDS Res. Hum. Retroviruses 25: 1005-1011, 2009.
Auwanit, W., Isarangkura-na-ayuthaya, P., Kasornpikul, D., Ikuta, K., Sawanpanyalert,
P. and Kameoka, M. Detection of drug resistance-associated and background
mutations in human immunodeficiency virus type 1 CRF01_AE protease and
reverse transcriptase derived from drug treatment-naive patients residing
in central Thailand. AIDS Res. Hum. Retroviruses 25: 625-631, 2009.
Siripanyaphinyo, U., Laohasinnarong, D., Siripanee, J., Kaeoket, K., Kameoka, M., Ikuta, K. and Sawanpanyalert, P. Full-length sequence of genotype 3 hepatitis E virus derived from a pig in Thailand. J. Med. Virol. 81: 657-664, 2009.
Utachee, P., Jinnopat, P., Isarangkura-na-ayuthaya, P., de Silva, U. C., Nakamura, S., Siripanyaphinyo, U., Wichukchinda, N., Tokunaga, K., Yasunaga, T., Sawanpanyalert, P., Auwanit, W., Ikuta, K. and Kameoka, M. Phenotypic studies on recombinant human immunodeficiency virus type 1 (HIV-1) containing CRF01_AE env gene derived from HIV-1-infected patient residing in central Thailand. Microbes Infect. 11: 334-343, 2009.
Utachee, P., Jinnopat, P., Isarangkura-na-ayuthaya, P., de Silva, U. C., Nakamura, S., Siripanyaphinyo, U., Wichukchinda, N., Tokunaga, K., Yasunaga, T., Sawanpanyalert, P., Auwanit, W., Ikuta, K. and Kameoka, M. Genotypic characterization of CRF01_AE env genes derived from human immunodeficiency virus type 1-infected patients residing in central Thailand. AIDS Res. Hum. Retroviruses 25: 229-236, 2009.
2008:
Iwabu, Y., Mizuta, H., Kawase, M., Kameoka, M., Goto, T. and Ikuta, K. Superinfection of defective human immunodeficiency virus type 1 with different subtypes of wild-type virus efficiently produces infectious variants with the initial viral phenotypes by complementation followed by recombination. Microbes Infect. 10: 504-513, 2008.
Kitagawa, Y., Kameoka, M., Shoji-Kawata, S., Iwabu, Y., Mizuta, H., Tokunaga, K., Fujino, M., Natori, Y.,Yura, Y. and Ikuta, K. Inhibitory function of adapter-related protein complex 2 alpha 1 subunit in the process of nuclear translocation of human immunodeficiency virus type 1 genome. Virology 373: 171-180, 2008.
2007:
Shoji-Kawata, S., Zhong, Q., Kameoka, M., Iwabu, Y., Sapsutthipas, S., Luftig, R. B. and Ikuta, K. The RING finger ubiquitin ligase RNF125/TRAC-1 down-modulates HIV-1 replication in primary human peripheral blood mononuclear cells. Virology 368: 191-204, 2007.
Kameoka, M., Kitagawa, Y., Utachee, P., Jinnopat, P., Dhepakson, P., Isarangkura-na-ayuthaya, P., Tokunaga, K., Sato, H., Komano, J., Yamamoto, N., Oguchi, S., Natori, Y. and Ikuta, K. Identification of the suppressive factors for human immunodeficiency virus type-1 replication using the siRNA mini-library directed against host cellular genes. Biochem. Biophys. Res. Commun. 359: 729-734, 2007.
Lau, T. S., Li, Y. G., Kameoka, M., Ng, T. B. and Wan, D. C.-C. Suppression of HIV Replication using RNA Interference against HIV-1 Integrase. FEBS lett. 581: 3253-3259, 2007.
2006:
Iwabu, Y., Goto, T., Tsuji, S., Warachit, J., Li,G. M., Shoji, S., Kameoka, M. and Ikuta, K. Superinfection of human immunodeficiency virus type 1 (HIV-1) to cell clone persistently infected with defective virus induces production of highly cytopathogenic HIV-1. Microbes Infect. 8: 1773-1782, 2006.
Tanaka, Y., Ota, K., Kameoka, M., Itaya, A. and Yoshihara, K. Up-regulation of NF-kB-responsive gene expression by DNp73a in p53 null cells. Exp. Cell Res. 312: 1254-1264, 2006.
2005:
Kameoka, M., Nukuzuma, S., Itaya, A., Tanaka, Y., Ota, K., Inada, Y., Ikuta, K. and Yoshihara, K. Poly(ADP-ribose)polymerase-1 is required for integration of the human immunodeficiency virus type 1 genome near centromeric alphoid DNA in human and murine cells. Biochem. Biophys. Res. Commun. 334: 412-417, 2005.
Li, Y. G, Iwabu, Y., Warachit, J., Kinomoto, M., Ibrahim, M. S., Tsuji, S., Mukai, T., Kameoka, M., Tokunaga, K., Sata, T. and Ikuta, K. Interleukin-4 Up-Regulates T-Tropic Human Immunodeficiency Virus Type 1 Transcription in Primary CD4(+) CD38(+) T-Lymphocyte Subset. Microbiol. Immunol. 49 (2): 155-165, 2005.
2004:
Kameoka, M., Nukuzuma, S., Itaya, A., Tanaka, Y., Ota, K., Ikuta, K., and Yoshihara, K. RNA Interference directed against poly(ADP-ribose) polymerase-1 efficiently suppresses human immunodeficiency virus type 1 replication in human cells. J. Virol. 78: 8931-8934, 2004.
Tanaka, Y., Kameoka, M., Itaya, A., Ota, K. and Yoshihara, K. Regulation of HSF1-responsive gene expression by N-terminal truncated form of p73a. Biochem. Biophys. Res. Commun. 317: 865-872, 2004.
Liang, C., Hu, J., Russell, R. S., Kameoka, M. and Wainberg, M. A. Spliced human immunodeficiency virus type 1 RNA is reverse transcribed into cDNA within infected cells. AIDS Res. Hum. Retroviruses 20: 203-211, 2004.
2003:
Ota, K., Kameoka, M., Tanaka, Y., Itaya, A. and Yoshihara, K. Expression of histone acetyltransferases was down-regulated in Poly(ADP-ribose) polymerase-1-deficient murine cells. Biochem. Biophys. Res. Commun. 310: 312-317, 2003
Guo, X., Kameoka, M., Wei, X., Roques, B., Gotte, M., Liang, C. and Wainberg, M. A. Suppression of an intrinsic strand transfer activity of HIV-1 Tat protein by its second-exon sequences. Virology 307: 154-163, 2003.
2002:
Kameoka, M., Morgan, M., Binette, M., Russell, R. S., Rong, L., Guo, X., Mouland, A., Kleiman, L., Liang, C. and Wainberg, M. A. The Tat protein of human immunodeficiency virus type1 can promote placement of tRNA primer onto viral RNA and suppress later DNA polymerization in HIV-1 reverse transcription. J. Virol. 76: 3637-3645, 2002.
Ota K., Yakovlev A.G., Itaya A., Kameoka M., Tanaka Y. and Yoshihara K. Alteration of Apoptotic Protease-Activating Factor-1 (APAF-1)-Dependent Apoptotic Pathway During Development of Rat Brain and Liver. J. Biochem. (Tokyo) 131: 131-135, 2002.
2001:
Kameoka, M., Rong, L., Gotte, M., Liang, C., Russell, R. S. and Wainberg, M. A. A Role for the Tat Protein of HIV-1 in Suppression of Viral Reverse Transcriptase Activity during Late Stages of Viral Replication. J. Virol. 75: 2675-2683, 2001.
Gotte, M., Kameoka, M., McLellan, N., Cellai, L. and Wainberg, M. A. Analysis of efficiency and fidelity of HIV-1 plus-strand DNA synthesis reveals a novel rate-limiting step during retroviral reverse transcription. J. Biol. Chem. 276: 6711-6719, 2001.
2000:
Bahmani, M. K., Kameoka, M., Goto, T., Sano, K., Luftig, R. B. and Ikuta, K. Fusion of uninfected T-cells occurs with immature HIV-1 protease-mutant, but not morphologically similar protease inhibitor derived particles. Virus Res. 66: 131-137, 2000.
Kameoka, M., Ota, K., Tetsuka, T., Tanaka, Y., Itaya, A., Okamoto, T. and Yoshihara, K. Evidence for regulation of NF-kB by poly (ADP-ribose) polymerase. Biochem. J. 346: 641-649, 2000.
Suzuki, S., Tobiume, M., Kameoka, M., Sato, K., Takahashi, T. A., Mukai, T. and Ikuta, K. Exposure of normal monocyte-derived dendritic cells to human immunodeficiency virus type-1 particles leads to the induction of apoptosis in co-cultured CD4+ as well as CD8+ T cells. Microbiol. Immunol. 44: 111-121, 2000.
1999:
Kameoka, M., Tanaka, Y., Ota, K., Itaya, A. and Yoshihara, K. Poly (ADP-ribose) polymerase is involved in PMA-induced activation of HIV-1 in U1 cells by modulating the LTR function. Biochem. Biophys. Res. Commun. 262: 285-289, 1999.
Kameoka, M., Tanaka, Y., Ota, K., Itaya, A., Yamamoto, K. and Yoshihara, K. HIV-1 Tat protein is poly(ADP-ribosyl)ated in vitro. Biochem. Biophys. Res. Commun. 261: 90-94, 1999.
Tanaka, Y., Kameoka, M., Ota, K., Itaya, A., Ikuta, K. and Yoshihara, K. Establishment of persistent infection with HIV-1 abrogates caspase-3-dependent apoptotic signaling pathway in U937 cells. Exp. Cell Res. 247: 514-524, 1999.
1998:
Kameoka, M., Auwanit, W., Suzuki, S., Horikoshi, H., Khlai-Khlam, N., Meguro, T., Yamada, K., Tanaka, Y., Yoshihara, K., Luftig, R. B. and Ikuta, K. A specific T-cell subset with CD4+/CD38- markers derived from HIV-1 carriers induces apoptosis in healthy donor-derived T-lymphocytes. Virus Res. 56: 115-122, 1998.
Tobiume, M., Fujinaga, K., Kameoka, M., Kimura, T., Nakaya, T., Yamada, T. and Ikuta, K. Dependence of host cell cycle for activation of HIV-1 gene expression from latency. J. Gen. Virol. 79: 1363-1371, 1998.
1997:
Ikuta, K., Kameoka, M. and Luftig, R. B. AIDS pathogenesis: the role of accessory gene mutations, leading to formation of long-lived persistently infected cells and/or apoptosis-inducing HIV-1 particles. Virus Res. 52: 145-156, 1997.
Suzuki, S., Kameoka, M., Nakaya, T., Kimura, T., Nishi, N. and Ikuta, K. Superoxide generation by monocytes following infection with human cytomegalovirus. Immunopharmacol. 37: 185-190, 1997.
Yoshihara, K., Ide, T., Ota, K., Tanaka, Y., Kameoka, M., Kumamoto, N. and Koide, S.S. Anti Ca2+, Mg2+-dependent endonuclease antibody which specifically detects this class of chromatin bound endonuclease from various tissues. Biochem. Biophys. Res. Commun. 236: 423-426, 1997.
Kameoka, M., Suzuki, S., Kimura, T., Fujinaga, K., Auwanit, W., Luftig, R. B. and Ikuta, K. Exposure of resting peripheral blood T-cells to HIV-1 particles generates CD25+ killer cells in a small subset, leading to induction of apoptosis in bystander cells. Int. Immunol. 9: 1453-1462, 1997.
Bahmani, M. K., Kameoka, M., Nakaya, T., Fujinaga, K., Zhong, Q., Takahashi, H., Nakano, T., Nakai, M., Ueda, S., Jones, I.M., Luftig, R. B. and Ikuta, K. Production of doughnut-shaped, protease-defective particles from a human T cell clone carrying a provirus with specific mutations in the env, pol, vpr, and nef genes. AIDS res. hum. retroviruses 13: 523-526, 1997.
Zheng, Y.-H. Nakaya, T., Sentsui, H., Kameoka, M., Kishi, M., Hagiwara, K., Takahashi, H., Kono, Y. and Ikuta, K. Insertions, duplications and substitutions in restricted gp90 regions of equine infectious anemia virus occurred during febrile episodes in an experimentally infected horses. J. Gen. Virol. 78: 807-820, 1997.
Kameoka, M., Kimura, T., Zheng, Y.-H. Suzuki, S., Fujinaga, K., Luftig, R. B. and Ikuta, K. Protease-defective, gp120-containing human immunodeficiency virus type 1 particles induce apoptosis more efficiently than dose wild-type virus or recombinant gp120 protein in healthy donor-derived peripheral blood T cells. J. Clin. Microbiol. 35: 41-47, 1997.
Zhong, Q., Nakaya, T., Tateno, Y., Fujinaga, K., Kameoka, M., Tateno, M. and Ikuta, K. A clearer distinction between HIV-1 paired isolates from peripheral blood mononuclear cells of asymptomatic carriers with and without CD8+ T-cells at nef rather than env V3 loci. Vaccine 15: 497-510, 1997.
Nakamura, Y., Kameoka, M., Tobiume, M., Kaya, M., Ohki, K., Yamada, T. and Ikuta, K. A chain section containing epitopes for cytotoxic T,B and helper T cells within a higyly conserved region found in the human immunodeficiency virus type 1 Gag protein. Vaccine 15: 489-496, 1997.
1996:
Kameoka, M., Kimura, T., Zhong, Q., Zheng, Y.-H., Luftig, R. B. and Ikuta, K. Induction of apoptosis by protease-defective particles of human immunodeficiency virus type-1 is specific to a subset of U937-derived subclones. Int. Immunol. 8: 1687-1697, 1996.
Kameoka, M., Okada, Y., Tobiume, M., Kimura, T. and Ikuta, K. Intracellelar glutathione as a possible direct blocker for HIV-1 reserse transcription. AIDS res. hum. retroviruses 12: 1635-1638, 1996.
Kameoka, M., Kimura, T., Okada, Y., Fujinaga, K., Nakaya, T., Takahashi, H., Kishi, M. and Ikuta, K. High susceptibility of U937-derived subclones to human immunodeficiency virus type 1 infection correlates with accumulation of unintegrated circular viral DNA. Virus Genes 12: 117-129, 1996.
Wada, N., Ohara, N., Kameoka, M., Nishino, Y., Matsumoto, S., Nishiyama, T., Naito, M., Yukitake, H., Okada, Y., Ikuta, K. and Yamada, T. Long-lasting immune response induced by recombinant Bacillus Calmette-Guerin (BCG) secretion system. Scand. J. Immunol. 43: 202-209, 1996.
1995:
Okada, Y., Kameoka, M., Kimura, T., Azuma, I. and Ikuta, K. Stimulation of human immunodeficiency virus type 1 infected cells with superoxide enhances the chemotactic motile response of CD4+ human T cells: implication for virus transmission by cell-to-cell interaction. Immunopharmacol. 31: 73-84, 1995.
Fujinaga, K., Zhong, Q., Nakaya, T., Kameoka, M., Megro, T., Yamada, K. and Ikuta, K. Extracellular Nef protein regulates productive HIV-1 infection from latency. J.Immunol. 155: 5289-5298, 1995
Tanaka, Y., Yoshihara, K., Tohno, Y., Kojima, K., Kameoka, M. and Kamiya,T. Inhibition and down-regulation of poly(ADP-ribose) polymerase results in a marked resistance of HL-60 cells to various apoptosis-inducers. Cell.Mol.Biol. 41: 771-781, 1995
Tanaka, Y., Yoshihara, K., Kojima, K., Itaya, A., Kameoka, M., Ikuta, K. and Kamiya, T. Poly(ADP-ribose) polymerase activity in various U937 cell subclones with different susceptibility to HIV-1 infection : Its dramatic decrease following persistent virus infection. Biochem. Biophys. Res. Commun. 213: 161-168, 1995.
Kameoka, M., Kimura, T., Okada, Y., Fujinaga, K., Nakaya, T., kishi, M. and Ikuta, K. High susceptibility of U937-derived subclone to infection with human immunodeficiency virus type 1 is correlated with virus-induced cell differentiation and superoxide generation. Immunopharmacol. 30: 89-101, 1995.
Okada, Y., Kimura, T., Kameoka, M., Kishi, M., Azuma, I. and Ikuta, K. Viral activation from latency during retrodifferentiation of U937 cells exposed to phorbol ester followed by infection with human immunodeficiency virus type 1. Immunopharmacol. 30: 27-39, 1995.
1994:
Otake, K., Fujii, Y., Nakaya, T., Nishino, Y., Zhong, Q., Fujinaga, K., Kameoka, M., Ohki, K. and Ikuta, K. The carboxyl-terminal region of HIV-1 Nef protein is a cell surface domain that can interact with CD4+ T cells. J. Immunol. 153: 5826-5837, 1994.
Nishino, Y., Kameoka, M., Okada, Y., Zhong Q., Kimura, T., Azuma, I. and Ikuta, K. In vivo induction of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes and delayed-type hypersensitivity by a 23-amino acid peptide from the highly conserved region in major core protein p24. Vaccine 12: 485-491, 1994.
Kameoka, M., Nishino, Y., Matsuo, K., Ohara, N., Kimura, T., Yamazaki, A., Yamada, T. and Ikuta, K. Cytotoxic T lymphocyte response in mice induced by a recombinant BCG vaccination which produces an extracellular α antigen that fused with the human immunodeficiency virus type 1 envelope immunodominant domain in the V3 loop. Vaccine 12: 153-158, 1994.
1993:
Kameoka, M., Kimura, T. and Ikuta, K. Superoxide enhances the spread of HIV-1 infection by cell-to-cell transmission. FEBS Lett. 331: 182-186, 1993.
Kimura, T., Kameoka, M. and Ikuta, K. Amplification of superoxide anion generation in phagocytic cells by HIV-1 infection. FEBS Lett. 326: 232-236, 1993. |
|
| |
|
|
| |
|
|
| |
|
|
|
